Publicacións en colaboración con investigadores/as de Centre Georges François Leclerc (1)

2014

  1. Randomized phase III study of erlotinib versus observation in patients with no evidence of disease progression after first-line platin-based chemotherapy for ovarian carcinoma: A European Organisation for Research and Treatment of Cancer-Gynaecological Cancer Group, and Gynecologic Cancer Intergroup study

    Journal of Clinical Oncology, Vol. 32, Núm. 4, pp. 320-326